CG
BBNX icon

Caprock Group’s Beta Bionics BBNX Stock Holding History

Caprock Group’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Sell
18,346
-501
-3% -$5.96K 0.01% 1045
2026
Q1 		$189K Buy
18,847
+6,730
+56% +$99.5K ﹤0.01% 1055
2025
Q4 		$369K Buy
12,117
+1,769
+17% +$47.2K 0.01% 923
2025
Q3 		$195K Buy
+10,348
New +$182K ﹤0.01% 1072

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Caprock Group's BBNX Position: Q2 2026 in Review

Caprock Group reduced its Beta Bionics (BBNX) stake by 2.7% in Q2 2026, selling an estimated $5.96K and leaving 18,346 shares worth $287K. The position accounts for 0.01% of the portfolio, ranked #1045.

Caprock Group first reported a position in BBNX in Q3 2025 and has held it in 4 quarters since. The position peaked at $369K in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Caprock Group held 18,346 shares of Beta Bionics worth $287K as of Q2 2026.
  • Caprock Group sold 501 Beta Bionics shares in Q2 2026, an estimated $5.96K.
  • Beta Bionics made up 0.01% of Caprock Group's portfolio in Q2 2026, its #1045 holding.
  • Caprock Group first reported a position in Beta Bionics in Q3 2025 and has held it in 4 quarters since.
  • Caprock Group's Beta Bionics position peaked at $369K in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.